Veno's Expectorant - Product Information
|Manufacture:||Forest Laboratories, Inc.|
|Condition:||Respiratory Tract Infection, Upper (Upper Respiratory Tract Infection)|
|Class:||Glucose elevating agents|
|Ingredients:||Guaifenesin, Glucose liquid, Treacle, Macrogol, glacial acetic acid, sodium benzoate (E 211), capsicum tincture, sodium metabisulphite (E 223), aniseed oil, xanthan gum, levomenthol, camphor, sodium cyclamate, acesulfame potassium, liquorice aniseed flavour and caramel colour (E 150).|
Name of the Medicinal Product
Qualitative and Quantitative Composition
Guaifenesin BP 100mg, Liquid Glucose BPC (1963) 3.0g, Treacle 1.35g
An expectorant for the symptomatic relief of coughs (including bronchial cough) and chesty catarrh, particularly associated with colds and flu.
The product also has a soothing, protective, demulcent action on a sore, irritated, tickling and inflamed throat.
Posology and Method of Administration
Adults and children over the age of 12
Take one 10ml dose (two 5ml spoonfuls) and repeat every 2 to 3 hours.
Route of Administration
Known hypersensitivity to guaifenesin, treacle, glucose or to any of the excipients.
Special Warnings and Precautions for Use
Patients suffering from chronic cough or asthma should consult a physician before taking this product.
Patients should stop using the product and consult a health care professional if cough lasts for more than 5 days or comes back, or is accompanied by a fever, rash or persistent headache.
Do not take with a cough suppressant.
Special Label Warnings
Keep out of the reach and sight of children.
If symptoms persist, consult your doctor.
Do not exceed the stated dose.
Do not use with other cough and cold medicines.
Contains 6.68g total sugars per 10ml dose. This should be taken into account in patients with diabetes mellitus.
Patients with rare glucose-galactose malabsorption should not take this medicine.
Contains 9.6mg sodium per 10ml dose. This should be taken into consideration in patients on a controlled sodium diet.
Contains sodium benzoate and sodium metabisulphite, which may rarely cause severe allergic reactions and bronchospasm.
Interaction With Other Medicinal Products and Other Forms of Interaction
Pregnancy and Lactation
Use in pregnancy and lactation is not contraindicated. However, as with all medicines, caution should be exercised during pregnancy and lactation.
Effects on Ability to Drive and Use Machines
Immune system disorders
Unknown: allergic reactions, angioedema, anaphylactic reactions
Respiratory, thoracic and mediastinal disorders
Unknown: Dyspnoea (in association with other symptoms of hypersensitivity)
Skin and subcutaneous disorders
Unknown: Rash, urticaria
Unknown: nausea, vomiting, abdominal discomfort
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard.
Very large doses of guaifenesin cause nausea and vomiting. Vomiting would be treated by fluid replacement and monitoring of electrolytes if indicated.
Guaifenesin is an expectorant.
Treacle and Liquid Glucose are demulcents.
Preclinical Safety Data
There are no preclinical data of any relevance additional to that already included in other sections of the SPC.
List of Excipients
Glacial acetic acid
Sodium benzoate (E211)
Sodium metabisulphite (E223)
Liquorice aniseed flavour
Caramel colour (E150)
Unopened: Three years
Opened: Six months
Special Precautions for Storage
Nature and Contents of Container
Amber cylindrical glass bottle fitted with a child resistant and tamper evident plastic screw cap.
Pack size: 100 or 160ml.
Special Precautions for Disposal and Other Handling
Marketing Authorisation Holder
Forest Laboratories UK Limited,
Marketing Authorisation Number(s)
Date of First Authorisation/Renewal of the Authorisation
31/01/1983 / 06/09/2004
Date of Revision of the Text
Company Contact Details
Forest Laboratories UK Limited (a subsidiary of Actavis PLC)
Whiddon Valley, Barnstaple, Devon, EX32 8NS, UK
+44 (0)1271 311 200
Fax Medical Information
+44 (0)1271 346106
+44(0)1271 385 257
Medical Information e-mail